CorrlensCorrlens
Correlate

Correlation Analysis

United Therapeutics Corp vs VISA Inc.

UTHR vs V

+0.741

Strong positive

When one moves up, the other tends to follow.

UTHR logo

United Therapeutics Corp

UTHR

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.

Market cap 24.5B · 1,400 employees

V

VISA Inc.

V

Visa is the largest payment processor in the world. In fiscal 2025, it processed almost $17 trillion in total volume. Visa operates in over 200 countries and processes transactions in over 160 currencies. Its systems are capable of processing over 65,000 transactions per second.

Market cap 583.4B

Apr 9, 2021 — Apr 7, 2026Daily1,254 data pointsStockStockFinancials

Time Series

Relative Performance

Green: UTHRGray: V36 of 1,254 points (sampled)

Who Moves First

UTHR leads V by 6 days

UTHR tends to move before V.

After testing 13 timing shifts, the strongest relationship was +0.746 (they moved in the same direction).

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

-0.263

13 periods · Return correlation when both series rose

Both Falling

+0.816

9 periods · Return correlation when both series fell

Diverging

-0.748

13 periods · Return correlation when series moved apart

R-Squared

54.9%

Share of variance in one series explained by the other.

Trend Agreement

56.1%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,254

Deep shared window — 1,254 usable pairs.

Significance

p < 0.001

95% CI: [0.715, 0.765]

Scatter

XY Regression

147200300400500597192.8200250300350372.1United Therapeutics CorpVISA Inc.Data pointsFit (r = 0.741)

Pipeline

Data quality details

Pipeline Summary

1,254 paired data points survived the daily window.

Raw input

1,254

1,254

Normalized

1,254

1,254

Prepared

1,254

1,254

Aligned

1,254

1,254

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

0

A: 0 / B: 0

Series A

UTHR logo

United Therapeutics Corp

UTHR

Market cap 24.5B · 1,400 employees

Stock · 1,254 raw → 1,254 prepared

Series B

V

VISA Inc.

V

Market cap 583.4B

Stock · 1,254 raw → 1,254 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

19

Estimated crossover points between normalized spreads.

Slope

0.4213

Linear regression slope.

Intercept

146.4223

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 7 hours ago · ID: stock-uthr-vs-stock-v-daily